Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | %Female (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Pharmaceutical Design | journal | 1.295 Q1 | 183 | 659 | 1399 | 71581 | 5281 | 1284 | 3.55 | 108.62 | 40.30 | |
2 | Current Medicinal Chemistry | journal | 1.373 Q1 | 202 | 359 | 1223 | 41513 | 5433 | 1164 | 4.02 | 115.64 | 39.58 | |
3 | Current Topics in Medicinal Chemistry | journal | 1.268 Q1 | 133 | 241 | 600 | 23758 | 2286 | 526 | 3.62 | 98.58 | 34.10 | |
4 | Current Drug Targets | journal | 1.548 Q1 | 119 | 174 | 546 | 14997 | 2193 | 496 | 3.67 | 86.19 | 37.68 | |
5 | Mini-Reviews in Medicinal Chemistry | journal | 0.939 Q2 | 107 | 164 | 355 | 14556 | 1230 | 337 | 3.42 | 88.76 | 38.36 | |
6 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.122 Q1 | 108 | 174 | 321 | 13259 | 994 | 287 | 2.85 | 76.20 | 37.06 | |
7 | Current Vascular Pharmacology | journal | 0.783 Q2 | 69 | 94 | 268 | 10596 | 775 | 248 | 2.82 | 112.72 | 30.09 | |
8 | CNS and Neurological Disorders - Drug Targets | journal | 1.287 Q1 | 96 | 140 | 308 | 10449 | 972 | 269 | 2.61 | 74.64 | 42.80 | |
9 | Current Cancer Drug Targets | journal | 1.585 Q1 | 103 | 82 | 269 | 8657 | 1036 | 249 | 3.79 | 105.57 | 38.44 | |
10 | Current Neuropharmacology | journal | 0.951 Q2 | 103 | 48 | 170 | 6542 | 547 | 161 | 2.60 | 136.29 | 49.66 | |
11 | Current Nanoscience | journal | 0.505 Q2 | 52 | 127 | 358 | 4915 | 634 | 350 | 1.69 | 38.70 | 31.02 | |
12 | Current Gene Therapy | journal | 2.047 Q1 | 80 | 46 | 142 | 4073 | 754 | 126 | 5.45 | 88.54 | 43.02 | |
13 | Medicinal Chemistry | journal | 0.350 Q3 | 50 | 118 | 267 | 3731 | 358 | 260 | 1.34 | 31.62 | 35.92 | |
14 | Combinatorial Chemistry and High Throughput Screening | journal | 0.542 Q2 | 70 | 90 | 279 | 3712 | 520 | 255 | 2.06 | 41.24 | 31.85 | |
15 | Letters in Drug Design and Discovery | journal | 0.294 Q2 | 37 | 131 | 375 | 3537 | 410 | 371 | 0.97 | 27.00 | 34.92 | |
16 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.162 Q1 | 52 | 24 | 77 | 3422 | 229 | 71 | 2.84 | 142.58 | 36.67 | |
17 | Current Computer-Aided Drug Design | journal | 0.511 Q2 | 32 | 52 | 84 | 3394 | 162 | 76 | 1.77 | 65.27 | 26.32 | |
18 | Infectious Disorders - Drug Targets | journal | 0.707 Q2 | 61 | 38 | 139 | 2911 | 264 | 125 | 1.68 | 76.61 | 37.21 | |
19 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 56 | 104 | 2752 | 271 | 100 | 2.28 | 49.14 | 30.26 | ||
20 | Current Drug Delivery | journal | 0.677 Q1 | 72 | 80 | 183 | 2491 | 439 | 176 | 2.64 | 31.14 | 33.48 | |
21 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.424 Q3 | 28 | 23 | 74 | 2456 | 126 | 72 | 2.38 | 106.78 | 45.71 | |
22 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.495 Q3 | 45 | 26 | 75 | 2332 | 108 | 69 | 1.10 | 89.69 | 37.35 | |
23 | Current Drug Discovery Technologies | journal | 0.714 Q2 | 49 | 33 | 101 | 2258 | 273 | 91 | 2.40 | 68.42 | 35.05 | |
24 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 23 | 74 | 2232 | 146 | 72 | 2.16 | 97.04 | 25.71 | ||
25 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 24 | 71 | 2171 | 145 | 69 | 2.10 | 90.46 | 41.30 | ||
26 | International Journal of Genomics | journal | 37 | 44 | 0 | 2112 | 0 | 0 | 0.00 | 48.00 | 30.23 | ||
27 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.580 Q2 | 43 | 37 | 82 | 2080 | 143 | 79 | 1.58 | 56.22 | 40.00 | |
28 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.160 Q4 | 27 | 29 | 108 | 2027 | 52 | 97 | 0.51 | 69.90 | 44.58 | |
29 | Recent Patents on CNS Drug Discovery | journal | 0.940 Q2 | 36 | 18 | 64 | 2003 | 181 | 57 | 2.90 | 111.28 | 43.08 | |
30 | Current Molecular Pharmacology | journal | 1.455 Q1 | 49 | 20 | 71 | 1907 | 251 | 65 | 2.88 | 95.35 | 35.29 | |
31 | Current Pharmacogenomics and Personalized Medicine | journal | 0.262 Q3 | 20 | 38 | 103 | 1871 | 117 | 80 | 1.28 | 49.24 | 53.33 | |
32 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 22 | 58 | 1821 | 109 | 55 | 1.90 | 82.77 | 39.34 | ||
33 | Current Bioactive Compounds | journal | 0.288 Q2 | 31 | 27 | 98 | 1793 | 72 | 86 | 0.64 | 66.41 | 39.02 | |
34 | Current Pharmaceutical Analysis | journal | 0.294 Q2 | 27 | 44 | 108 | 1755 | 117 | 107 | 0.80 | 39.89 | 40.74 | |
35 | Current Enzyme Inhibition | journal | 0.231 Q3 | 19 | 18 | 60 | 1416 | 41 | 55 | 0.51 | 78.67 | 39.53 | |
36 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.181 Q3 | 17 | 27 | 85 | 1397 | 35 | 79 | 0.46 | 51.74 | 36.44 | |
37 | Current Drug Therapy | journal | 0.126 Q4 | 20 | 21 | 106 | 1374 | 30 | 99 | 0.33 | 65.43 | 48.28 | |
38 | Current Radiopharmaceuticals | journal | 0.555 Q3 | 32 | 26 | 107 | 1359 | 162 | 98 | 1.40 | 52.27 | 39.13 | |
39 | Journal of Toxicology | journal | 0.642 Q2 | 47 | 27 | 117 | 1349 | 284 | 113 | 2.55 | 49.96 | 39.20 | |
40 | Current Drug Safety | journal | 0.539 Q3 | 41 | 39 | 170 | 925 | 283 | 157 | 1.28 | 23.72 | 37.40 | |
41 | Anti-Infective Agents | journal | 0.200 Q3 | 26 | 15 | 45 | 885 | 33 | 43 | 0.70 | 59.00 | 58.62 | |
42 | Reviews on Recent Clinical Trials | journal | 0.611 Q2 | 35 | 21 | 95 | 788 | 166 | 92 | 1.69 | 37.52 | 20.00 | |
43 | Drug Metabolism Letters | journal | 0.340 Q2 | 31 | 26 | 101 | 697 | 128 | 100 | 1.20 | 26.81 | 30.77 | |
44 | Jordan Journal of Pharmaceutical Sciences | journal | 0.159 Q3 | 12 | 22 | 65 | 595 | 19 | 65 | 0.27 | 27.05 | 31.34 | |
45 | Bulletin of Pharmaceutical Sciences. Assiut | journal | 0.146 Q3 | 10 | 10 | 49 | 279 | 13 | 49 | 0.29 | 27.90 | 54.29 | |
46 | Open Medicinal Chemistry Journal | journal | 1.227 Q1 | 23 | 7 | 23 | 247 | 102 | 21 | 4.35 | 35.29 | 43.59 | |
47 | Current Clinical Pharmacology | journal | 0.705 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
48 | Open Drug Discovery Journal | journal | 0.384 Q3 | 10 | 0 | 26 | 0 | 30 | 23 | 0.00 | 0.00 | 0.00 | |
49 | Recent Patents on Drug Delivery and Formulation | journal | 0.463 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
50 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.575 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®